NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Mary Wood
Oregon Health & Science University - Portland / United States
Medical and Health Sciences / Health Sciences
AD Scientific Index ID: 893709
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Mary Wood's MOST POPULAR ARTICLES
1-)
Human leukocyte antigen susceptibility map for SARS-CoV-2A Nguyen, JK David, SK Maden, MA Wood, BR Weeder, A Nellore, ...Journal of Virology, 2020490*2020
2-)
Androgen receptor activity in T cells limits checkpoint blockade efficacyX Guan, F Polesso, C Wang, A Sehrawat, RM Hawkins, SE Murray, ...Nature, 1-6, 2022632022
3-)
A phase II single-arm study of pembrolizumab with enzalutamide in men with metastatic castration-resistant prostate cancer progressing on enzalutamide aloneJN Graff, TM Beer, JJ Alumkal, RE Slottke, WL Redmond, GV Thomas, ...Journal for immunotherapy of cancer 8 (2), 2020602020
4-)
Burden of tumor mutations, neoepitopes, and other variants are weak predictors of cancer immunotherapy response and overall survivalMA Wood, BR Weeder, JK David, A Nellore, RF ThompsonGenome medicine 12, 1-16, 2020742020
5-)
Pembrolizumab (Pembro) plus enzalutamide (Enz) in metastatic castration resistant prostate cancer (mCRPC): Extended follow up.JN Graff, JJ Alumkal, RF Thompson, A Moran, GV Thomas, MA Wood, ...Journal of Clinical Oncology 36 (15_suppl), 5047-5047, 2018432018
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept